A new Forstmann, Little unit will buy Sybron.

The New York investment firm, which specializes in leveraged buy-outs, said it will create a subsidiary to acquire Sybron, a medical products firm, for $300 million. The companies said that as a first step in the transaction, Sybron and SC Acquisition Corp., the new Forstmann, Little unit, are commencing a joint tender offer for Sybron common shares at $26.25 per share. The offer is subject to the purchase by SC Acquisition of two-thirds of all outstanding Sybron shares by Feb. 24. The tender offer also covers all shares of Sybron convertible preferred stock at a price of $42 per share.